KRT7 and neoplasm: It appears that both CK7 and MUC5AC metaplastic markers were largely expressed in cancers, being present in 52% and 44% of cases, respectively, while as many as 67% of tumours (35 cases) showed at least one of the two markers and 29% (15 cases) both markers.